An overview of oculocutaneous albinism: TYR gene mutations in five Colombian individuals

Diana Sanabria, Helena Groot, Julio Guzmán, María Claudia Lattig, .

Keywords: Albinism, , oculocutaneus, monofenol monooxigenasa, mutation, contact lenses, Colombia

Abstract

Introduction. Oculocutaneus albinism is a pigment-related inherited disorder characterized by hypopigmentation of the skin, hair and eyes, foveal hypoplasia and low vision. To date, 230 mutations in the TYR gene have been reported as responsible for oculocutaneus albinism type 1 worldwide. TYR gene encodes the enzyme tyrosinase involved in the metabolic pathway of melanin synthesis.

Objectives. Mutations were identified in the TYR gene as responsible for oculocutaneous albinism type 1 in five Colombian individuals, and a new ophthalmic system was tested that corrected visual defects and symptoms in a patient with oculocutaneous albinism.

Materials and methods. Samples were taken from 5 individuals, four of whom belong to a single family, along with a fifth individual not related to the family. Five exons in the TYR gene were sequenced to search for the gene carriers in the family and in the non-related individual. In addition, clinical ophthalmological evaluation and implementation of an new oculo-visual system was undertaken.

Results. A G47D and 1379delTT mutation was identified in the family. The unrelated individual carried a compound heterozygote for the G47D and D42N mutations. The oculo-visual corrective system was able to increase visual acuity and to diminish the nystagmus and photophobia.

Conclusions. This is the first study in Colombia where albinism mutations are reported. The methods developed will enable future molecular screening studies in Colombian populations.

Downloads

Download data is not yet available.
  • Diana Sanabria Laboratorio de Genética Humana, Facultad de Ciencias, Departamento de Ciencias Biológicas, Universidad de los Andes, Bogotá, D.C., Colombia
  • Helena Groot Laboratorio de Genética Humana, Facultad de Ciencias, Departamento de Ciencias Biológicas, Universidad de los Andes, Bogotá, D.C., Colombia
  • Julio Guzmán Centro de Investigación y Desarrollo, Facultad de Optometría, Fundación Universitaria del Área Andina, Bogotá, D.C., Colombia
  • María Claudia Lattig Laboratorio de Genética Humana, Facultad de Ciencias, Departamento de Ciencias Biológicas, Universidad de los Andes, Bogotá, D.C., Colombia

References

Zhao H, Boissy RE. Distinguishing between the catalytic potential and apparent expression of tyrosinase activities. Am J Med Sci. 994;308:322-30.

Witkop CJ. Albinism: Hematologic-storage disease, susceptibility to skin cancer, and optic neuronal defects shared in all types of oculocutaneous and ocular albinism. Ala J Med Sci. 1979;16:327-30.

PMid:546241

Gronskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis. 2007;2:43. doi: http://dx.doi.org/10.1186/1750-1172-2-43

Meyer CH, Lapolice DJ, Freedman SF. Foveal hypoplasia in oculocutaneous albinism demonstrated by optical coherence tomography. Am J Ophthalmol. 2002;133:409-10. doi: http://dx.doi.org/10.1016/S0002-9394(01)01326-5

Creel D. Problems of ocular miswiring in albinism, Duane’s syndrome, and Marcus Gunn phenomenon. Int Ophthalmol Clin. 1984;24:165-76. doi: http://dx.doi.org/10.1097/00004397-198402410-00013

Creel DJ, Summers CG, King RA. Visual anomalies associated with albinism. Ophthalmic Paediatr Genet. 1990;11:193-200. doi: http://dx.doi.org/10.3109/13816819009020979

Abadi RV. Mechanisms underlying nystagmus. J R Soc Med. 2002;95:231-4.

doi: http://dx.doi.org/10.1258/jrsm.95.5.231

King RA, Pietsch J, Fryer JP, Savage S, Brott MJ, Russell-Eggitt I, et al. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet. 2003;113:502-13. doi: http://dx.doi.org/10.1007/s00439-003-0998-1

King RA, Hearing VJ, Creel D, Oetting WS. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle DY, editors. The metabolic and molecular basis of inherited disease. Séptima edición. New York: McGraw-Hill; 1995. p. 4353-92.

Sinclair FG. El albinismo entre los amerindios de Panamá. Scientia (Panama). 1989;4:41-50.

Soto-Calderón ID. Evaluación histórica y genética del origen de Marinilla y su zona de influencia. Medellin: Universidad de Antioquia; 2003.

Tirado-Muñoz MC. Estudio de la isonimia en el albinismo de la población de El Santuario. Medellin: Universidad de Antioquia; 1987.

Bravo-Aguilar ML. Estudio genético epidemiológico del albinismo como un pro regional de El Santuario 1990 (tesis). Medellín: Universidad de Antioquia; 1990.

Barton DE, Kwon BS, Francke U. Human tyrosinase gene, mapped to chromosome 11 (q14----q21), defines second region of homology with mouse chromosome 7. Genomics. 1988;3:17-24. doi: http://dx.doi.org/10.1016/0888-7543(88)90153-X

Kwon BS, Haq AK, Kim GS, Pomerantz SH, Halaban R. Cloning and characterization of a human tyrosinase cDNA. Prog Clin Biol Res. 1988;256:273-82. PMid:2835779

Cooksey CJ, Garratt PJ, Land EJ, Pavel S, Ramsden CA, Riley PA, et al. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. J Biol Chem. 1997;272:26226-35. doi: http://dx.doi.org/10.1074/jbc.272.42.26226

Oetting WS, Fryer JP, Shriram S, King RA. Oculocutaneous albinism type 1: The last 100 years. Pigment cell research/sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society. 2003;16:307-11.

Oetting WS, Garrett SS, Brott M, King RA. P gene mutations associated with oculocutaneous albinism type II (OCA2). Hum Mutat. 2005;25:323. doi: http://dx.doi.org/10.1002/humu.9318

Chaki M, Mukhopadhyay A, Ray K. Determination of variants in the 3’-region of the tyrosinase gene requires locus specific amplification. Hum Mutat. 2005;26:53-8. doi: http://dx.doi.org/10.1002/humu.20171

Oetting WS, King RA. Molecular basis of albinism: Mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat. 1999;13:99-115. doi: http://dx.doi.org/10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.0.CO;2-C

Sundaresan P, Sil AK, Philp AR, Randolph MA, Natchiar G, Namperumalsamy P. Genetic analysis of oculocutaneous albinism type 1 (OCA1) in Indian families: Two novel frameshift mutations in the TYR Gene. Mol Vis. 2004;10:1005-10. PMid:15635296

Chaki M, Mukhopadhyay A, Chatterjee S, Das M, Samanta S, Ray K. Higher prevalence of OCA1 in an ethnic group of eastern India is due to a founder mutation in the tyrosinase gene. Mol Vis. 2005;11:531-4. PMid:16056219

Giebel LB, Spritz RA. RFLP for MboI in the human tyrosinase (TYR) gene detected by PCR. Nucleic Acids Res. 1990;18:3103. doi: http://dx.doi.org/10.1093/nar/18.10.3103-a

Gershoni-Baruch R, Rosenmann A, Droetto S, Holmes S, Tripathi RK, Spritz RA. Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel. Am J Hum Gen. 1994;54:586-94. PMid:8128955 PMCid:1918101

Oetting WS, Witkop CJ, Jr., Brown SA, Colomer R, Fryer JP, Bloom KE, et al. A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico. Am J Hum Gen. 1993;52:17-23. PMid:8434585 PMCid:1682128

Santiago PJ, Rodríguez-Pérez Y, Renta JY, Izquierdo NJ, Del Fierro L, Munoz D, et al. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico. J Invest Dermatol. 2006;126:85-90. doi: http://dx.doi.org/10.1038/sj.jid.5700034

Opitz S, Kasmann-Kellner B, Kaufmann M, Schwinger E, Zuhlke C. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism. Hum Mutat. 2004;23:630-1. doi: http://dx.doi.org/10.1002/humu.9248

Hutton SM, Spritz RA. Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type. J Invest Dermatol. 2008;128:2442-50. doi: http://dx.doi.org/10.1038/jid.2008.109

Ladero-Quesada MA, Valdeón BJ, Alcala-Galve J. Judíos sefarditas conversos: la expulsión de 1492 y sus consecuencias. Valladolid: Ámbito Editores S.A.; 1995.

Wilson R. The National Organization for Albinism and Hypopigmentation (NOAH). Insight. 1993;18:8.

Hertle RW, Anninger W, Yang D, Shatnawi R, Hill VM. Effects of extraocular muscle surgery on 15 patients with oculo-cutaneous albinism (OCA) and infantile nystagmus syndrome (INS). Am J Ophthalmol. 2004;138:978-87. doi: http://dx.doi.org/10.1016/j.ajo.2004.07.029

Gauthier CA, Grant T, Holden BA. Clinical performance of two opaque, tinted soft contact lenses. J Am Optom Assoc. 1992;63:344-9. PMid:1593071

How to Cite
1.
Sanabria D, Groot H, Guzmán J, Lattig MC. An overview of oculocutaneous albinism: TYR gene mutations in five Colombian individuals. biomedica [Internet]. 2012 Jun. 30 [cited 2024 May 12];32(2):269-76. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/638

Some similar items:

Published
2012-06-30
Section
Short communication

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
QR Code